<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02241928</url>
  </required_header>
  <id_info>
    <org_study_id>NGBSI-14</org_study_id>
    <nct_id>NCT02241928</nct_id>
  </id_info>
  <brief_title>Stem Cell Therapy in Muscular Dystrophy</brief_title>
  <official_title>Role of Autologous Mononuclear Cell Therapy in Muscular Dystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neurogen Brain and Spine Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Neurogen Brain and Spine Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to analyze the effect of autologous bone marrow mononuclear
      cells in muscular dystrophy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Manual Muscle Testing</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Muscular Dystrophy</condition>
  <arm_group>
    <arm_group_label>Stem Cell</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bone marrow mononuclear cell transplantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Stem Cell</intervention_name>
    <description>Intrathecal Autologous bone marrow mononuclear cell transplantation</description>
    <arm_group_label>Stem Cell</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age group of 6 months and above

          -  muscular dystrophy diagnosed on the basis of clinical presentation

        Exclusion Criteria:

          -  presence of respiratory distress

          -  presence of acute infections such as Human Immunodeficient Virus/Hepatitis B
             Virus/Hepatitis C Virus

          -  malignancies

          -  acute medical conditions such as respiratory infection, fever, hemoglobin less than 8,
             bleeding tendency, bone marrow disorder, left ventricular ejection fraction &lt; 30%

          -  pregnancy or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alok K Sharma, M.S, M.Ch</last_name>
    <phone>022-25283706</phone>
    <email>alok276@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Neurogen brain and spine institute</name>
      <address>
        <city>Navi Mumbai</city>
        <state>Maharashtra</state>
        <zip>400706</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alok K Sharma, M.S, M.Ch</last_name>
      <phone>022-25283706</phone>
      <email>alok276@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Alok K Sharma, M.S, M.Ch</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2014</study_first_submitted>
  <study_first_submitted_qc>September 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2014</study_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Muscular Dystrophy</keyword>
  <keyword>Autologous Mononuclear cell therapy</keyword>
  <keyword>Stem Cell</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

